[Two cases of the primary small intestine cancer successfully treated with S-1 and UFT/LV therapy].

Abstract

The primary small intestinal cancer is rare in gastrointestinal cancer, and there are much advanced/recurrent cases. However, there were a few case reports about chemotherapy for advanced or recurrent small intestinal cancer, and a treatment resume was inconsistent. We reported that S-1 and UFT/LV therapy was effective with the two cases as an oral chemotherapy for the primary small intestinal cancer.

• Authors: Tomohiro Lee, Eiji Noda, Kiyoshi Maeda, Toru Inoue, Hisashi Nagahara, Ryosuke Amano, Naoshi Kubo, Hiroaki Tanaka, Kazuya Muguruma, Tsutomu Takashima, Nobuya Yamada, Masakazu Yashiro, Naoyoshi Onoda, Tetsuji Sawada, Bunzo Nakata, Masaichi Ohira, Tetsuro Ishikawa, Kosei Hirakawa
• Journal: Gan to kagaku ryoho. Cancer & chemotherapy (Gan To Kagaku Ryoho) Vol. 37 Issue 12 Pg. 2789-91 (Nov 2010) ISSN: 0385-0684 [Print] Japan
• PMID: 21224714 (Publication Type: Case Reports, English Abstract, Journal Article, Review)

Chemical References

• Antimetabolites, Antineoplastic
• Drug Combinations
• S 1 (combination)
• Tegafur
• Uracil
• Oxonic Acid
• Leucovorin

Topics

• Adenocarcinoma (drug therapy)
• Aged
• Antimetabolites, Antineoplastic (administration & dosage)
• Antineoplastic Combined Chemotherapy Protocols (administration & dosage, therapeutic use)
• Drug Combinations
• Humans
• Jejunal Neoplasms (drug therapy)
• Leucovorin (administration & dosage)
• Male
• Middle Aged
• Oxonic Acid (administration & dosage)
• Tegafur (administration & dosage)
• Uracil (administration & dosage)